These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2127269)

  • 21. Cefpodoxime proxetil in the treatment of skin and soft tissue infections.
    Tack KJ; Wilks NE; Semerdjian G; Frazier CH; Shirin K; Puopolo A; Crossland SG; Goffe BS; Millikan L
    Drugs; 1991; 42 Suppl 3():51-6. PubMed ID: 1726208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Observational study of the tolerance and effectiveness of cefpodoxim-proxetil in general practice].
    Hanke K; Blum SP
    Fortschr Med Orig; 2002; 120(1):21-8. PubMed ID: 14518354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trials of cefpodoxime proxetil suspension in paediatrics.
    Fujii R
    Drugs; 1991; 42 Suppl 3():57-60. PubMed ID: 1726209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
    Frampton JE; Brogden RN; Langtry HD; Buckley MM
    Drugs; 1992 Nov; 44(5):889-917. PubMed ID: 1280571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of cefpodoxime proxetil and cefixime in the treatment of acute otitis media in infants and children. Otitis Study Group.
    Asmar BI; Dajani AS; Del Beccaro MA; Mendelman PM
    Pediatrics; 1994 Dec; 94(6 Pt 1):847-52. PubMed ID: 7971000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefetamet in the treatment of acute sinusitis in adult patients.
    Gauger U; Inoka P; Germano G; Kissling M
    J Int Med Res; 1990; 18(3):228-34. PubMed ID: 2193836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cefpodoxime proxetil compared with amoxicillin-clavulanate for the treatment of otitis media.
    Mendelman PM; Del Beccaro MA; McLinn SE; Todd WM
    J Pediatr; 1992 Sep; 121(3):459-65. PubMed ID: 1517926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections].
    Xiao YH; Gao L; Li Y; Lü Y; Liu J; Liu Y
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1867-71. PubMed ID: 15631795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cefetamet pivoxil vs cefaclor in the treatment of acute otitis media in children.
    Furman S; Berkowicz L; Dippenaar J; Hellenberg DA; Montanus MS; Steinberg A; Schall R
    Drugs; 1994; 47 Suppl 3():21-6. PubMed ID: 7518763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cefpodoxime proxetil in upper respiratory tract infections.
    Bergogne-Berezin E
    Drugs; 1991; 42 Suppl 3():25-33. PubMed ID: 1726205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Respiratory tract infections in general practice. Cefpodoxime proxetil in patients with risk factors and concomitant illnesses].
    Kardos P; Wiese K
    MMW Fortschr Med; 2000 Feb; 142(5):41. PubMed ID: 10715939
    [No Abstract]   [Full Text] [Related]  

  • 32. Bioavailability of cefpodoxime proxetil with co-administered acetylcysteine.
    Kees F; Wellenhofer M; Bröhl K; Grobecker H
    Arzneimittelforschung; 1996 Apr; 46(4):435-8. PubMed ID: 8740095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Summary of clinical experience with cefpodoxime proxetil in adults in Japan.
    Kumazawa J
    Drugs; 1991; 42 Suppl 3():1-5. PubMed ID: 1726202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evaluation of cefpodoxime proxetil in patients with dermatological infections.
    Imaizumi T; Ishikawa H; Hashimoto I
    J Chemother; 1995 Nov; 7 Suppl 4():137-41. PubMed ID: 8904135
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of infectious complications affecting the skin and soft tissues with cefpodoxime proxetil].
    Vyhnánek F; Lochmann O
    Epidemiol Mikrobiol Imunol; 1996 May; 45(2):68-70. PubMed ID: 8756403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical evaluation of cefpodoxime proxetil in otorhinolaryngological infections].
    Takeuchi H; Ikoma H; Suzuki T; Nakajima M; Kouzaki Y; Ishizu Y; Makino H; Sugihara S; Ootawara S; Asagi K
    Jpn J Antibiot; 1994 Jan; 47(1):84-92. PubMed ID: 8114275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cefpodoxime-proxetil versus trimethoprim-sulfamethoxazole for short-term therapy of uncomplicated acute cystitis in women.
    Kavatha D; Giamarellou H; Alexiou Z; Vlachogiannis N; Pentea S; Gozadinos T; Poulakou G; Hatzipapas A; Koratzanis G
    Antimicrob Agents Chemother; 2003 Mar; 47(3):897-900. PubMed ID: 12604518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five day treatment of pharyngotonsillitis with cefpodoxime proxetil.
    Portier H; Chavanet P; Gouyon JB; Guetat F
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():79-85. PubMed ID: 2127268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multi-institutional study on clinical effectiveness of cefpodoxime proxetil dry syrup in childhood infections.
    Imanaka H; Kitahara T; Yoshinaga M; Miyata K
    J Chemother; 1995 Nov; 7 Suppl 4():131-3. PubMed ID: 8904133
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of cefpodoxime proxetil dry syrup in pediatric patients with various infections.
    Muranaka H; Yokoyama M
    J Chemother; 1995 Nov; 7 Suppl 4():127-30. PubMed ID: 8904132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.